Section Arrow
ASMB.NASDAQ
- Assembly Biosciences
Quotes are at least 15-min delayed:2026/08/31 08:08 EDT
Pre Market
Last
 --
-- (--)
Bid
33.34
Ask
36
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 34.07
-0.73 (-2.10%)
Day High 
34.58 
Prev. Close
34.8 
1-M High
37 
Volume 
250.03K 
Bid
33.34
Ask
36
Day Low
33.29 
Open
34.58 
1-M Low
24.5 
Market Cap 
708.55M 
Currency 美元 
P/E 28.06 
%Yield -- 
10-SMA 33.77 
20-SMA 30.26 
50-SMA 27.94 
52-W High 39.705 
52-W Low 20.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.24/-0.02
Enterprise Value
710.61M
Balance Sheet
Book Value Per Share
15.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
72.30M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNRXQuoin Pharmaceuticals Ltd6.12+0.965+18.72%-- 
Pre Market 5.4205 -0.6995 -11.43%
MRNAModerna137.99-4.78-3.35%-- 
Pre Market 134.46 -3.53 -2.56%
CELUCelularity1.58-0.52-24.76%-- 
Pre Market 1.4116 -0.1684 -10.66%
VBIOValion Bio Inc.0.1209-0.0017-1.39%-- 
Pre Market -- -- --
RXRXRecursion Pharmaceuticals3.34-0.1-2.91%-- 
Pre Market 3.32 -0.02 -0.60%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points.The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.